409 related articles for article (PubMed ID: 24992073)
1. A new 9-alkyladenine-cyclic methylglyoxal diadduct activates wt- and F508del-cystic fibrosis transmembrane conductance regulator (CFTR) in vitro and in vivo.
Boucherle B; Bertrand J; Maurin B; Renard BL; Fortuné A; Tremblier B; Becq F; Norez C; Décout JL
Eur J Med Chem; 2014 Aug; 83():455-65. PubMed ID: 24992073
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel water-soluble activator of wild-type and F508del CFTR: GPact-11a.
Bertrand J; Boucherle B; Billet A; Melin-Heschel P; Dannhoffer L; Vandebrouck C; Jayle C; Routaboul C; Molina MC; Décout JL; Becq F; Norez C
Eur Respir J; 2010 Aug; 36(2):311-22. PubMed ID: 20110398
[TBL] [Abstract][Full Text] [Related]
3. Discovery of alpha-aminoazaheterocycle-methylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels.
Routaboul C; Norez C; Melin P; Molina MC; Boucherle B; Bossard F; Noel S; Robert R; Gauthier C; Becq F; Décout JL
J Pharmacol Exp Ther; 2007 Sep; 322(3):1023-35. PubMed ID: 17578899
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Phe508 in the first nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone.
Scott-Ward TS; Amaral MD
FEBS J; 2009 Dec; 276(23):7097-109. PubMed ID: 19878303
[TBL] [Abstract][Full Text] [Related]
5. Discovery of pyrrolo[2,3-b]pyrazines derivatives as submicromolar affinity activators of wild type, G551D, and F508del cystic fibrosis transmembrane conductance regulator chloride channels.
Noel S; Faveau C; Norez C; Rogier C; Mettey Y; Becq F
J Pharmacol Exp Ther; 2006 Oct; 319(1):349-59. PubMed ID: 16829626
[TBL] [Abstract][Full Text] [Related]
6. Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.
Roxo-Rosa M; Xu Z; Schmidt A; Neto M; Cai Z; Soares CM; Sheppard DN; Amaral MD
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17891-6. PubMed ID: 17098864
[TBL] [Abstract][Full Text] [Related]
7. The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation.
Pasyk S; Molinski S; Ahmadi S; Ramjeesingh M; Huan LJ; Chin S; Du K; Yeger H; Taylor P; Moran MF; Bear CE
Proteomics; 2015 Jan; 15(2-3):447-61. PubMed ID: 25330774
[TBL] [Abstract][Full Text] [Related]
8. Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating.
Cai Z; Palmai-Pallag T; Khuituan P; Mutolo MJ; Boinot C; Liu B; Scott-Ward TS; Callebaut I; Harris A; Sheppard DN
J Physiol; 2015 Jun; 593(11):2427-46. PubMed ID: 25763566
[TBL] [Abstract][Full Text] [Related]
9. The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70.
Farinha CM; Nogueira P; Mendes F; Penque D; Amaral MD
Biochem J; 2002 Sep; 366(Pt 3):797-806. PubMed ID: 12069690
[TBL] [Abstract][Full Text] [Related]
10. Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTR.
Bose SJ; Bijvelds MJC; Wang Y; Liu J; Cai Z; Bot AGM; de Jonge HR; Sheppard DN
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L71-L86. PubMed ID: 30969810
[TBL] [Abstract][Full Text] [Related]
11. Identification of synergistic combinations of F508del cystic fibrosis transmembrane conductance regulator (CFTR) modulators.
Lin S; Sui J; Cotard S; Fung B; Andersen J; Zhu P; El Messadi N; Lehar J; Lee M; Staunton J
Assay Drug Dev Technol; 2010 Dec; 8(6):669-84. PubMed ID: 21050065
[TBL] [Abstract][Full Text] [Related]
12. Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTR.
Sampson HM; Robert R; Liao J; Matthes E; Carlile GW; Hanrahan JW; Thomas DY
Chem Biol; 2011 Feb; 18(2):231-42. PubMed ID: 21338920
[TBL] [Abstract][Full Text] [Related]
13. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
[TBL] [Abstract][Full Text] [Related]
14. F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.
Yang H; Ma T
Expert Opin Ther Pat; 2015; 25(9):991-1002. PubMed ID: 25971311
[TBL] [Abstract][Full Text] [Related]
15. Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant.
Yu W; Kim Chiaw P; Bear CE
J Biol Chem; 2011 Jul; 286(28):24714-25. PubMed ID: 21602569
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation.
Blanchard E; Marie S; Riffault L; Bonora M; Tabary O; Clement A; Jacquot J
Biochem Biophys Res Commun; 2011 Aug; 411(3):471-6. PubMed ID: 21723850
[TBL] [Abstract][Full Text] [Related]
17. Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect.
Robert R; Carlile GW; Pavel C; Liu N; Anjos SM; Liao J; Luo Y; Zhang D; Thomas DY; Hanrahan JW
Mol Pharmacol; 2008 Feb; 73(2):478-89. PubMed ID: 17975008
[TBL] [Abstract][Full Text] [Related]
18. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
[TBL] [Abstract][Full Text] [Related]
19. Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Chung WJ; Goeckeler-Fried JL; Havasi V; Chiang A; Rowe SM; Plyler ZE; Hong JS; Mazur M; Piazza GA; Keeton AB; White EL; Rasmussen L; Weissman AM; Denny RA; Brodsky JL; Sorscher EJ
PLoS One; 2016; 11(10):e0163615. PubMed ID: 27732613
[TBL] [Abstract][Full Text] [Related]
20. HGF stimulation of Rac1 signaling enhances pharmacological correction of the most prevalent cystic fibrosis mutant F508del-CFTR.
Moniz S; Sousa M; Moraes BJ; Mendes AI; Palma M; Barreto C; Fragata JI; Amaral MD; Matos P
ACS Chem Biol; 2013 Feb; 8(2):432-42. PubMed ID: 23148778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
